Año: 2015
Journal Impact Factor (JIF): 3.3110
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| NUTRITION & DIETETICS | SCIE | 23/80 | Q2 | T1 | D3 |
Año: 2017
Journal Citation Indicator (JCI): 1,100
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| NUTRITION & DIETETICS | 22/101 | Q1 | T1 | D3 | 78,71 |
Año:
2015
CiteScore:
6,600
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| General Medicine | 520/3276 | Q1 | T1 | D2 |
| Medicine (miscellaneous) | 27/179 | Q1 | T1 | D2 |
| Nutrition and Dietetics | 19/114 | Q1 | T1 | D2 |
SJR año:
2015
Factor de Impacto:
1,642
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Medicine (miscellaneous) | 248/2830 | Q1 | T1 | D1 |
| Nutrition and Dietetics | 18/129 | Q1 | T1 | D2 |
| Agencia | Código de Proyecto |
|---|---|
| Abbott Laboratories | - |
| Aegerion | - |
| Amgen | - |
| AstraZeneca | - |
| Beer and Health Foundation | - |
| Biomedical Research of the Spanish Government | RTIC G03/140 |
| California Walnut Commission | - |
| Cancer Prevention and Control from the Cancer Training Branch of the National Cancer Institute | K05 CA136975 |
| Centro Nacional de Investigaciones Cardiovasculares | CNIC 06/2007 |
| Cerveceros de Espana and Sanofi-Aventis | - |
| CIBERobn | - |
| Daiichi Sankyo | - |
| Damm | - |
| Danone | - |
| Eroski | - |
| European Foundation for Alcohol Research (ERAB) | - |
| Feiraco | - |
| Ferrer | - |
| Flora Foundation (Unilever) | - |
| Fondo de Investigacion Sanitaria Fondo Europeo de Desarrollo Regional | PI04-2239; PI05/2584; CP06/00100; PI07/0240; PI07/1138; PI07/0954; PI07/0473; PI10/01407; PI11/01647; PI1102505 |
| Fundacion Mapfre | - |
| Health Department of the Catalan Government (Generalitat de Catalunya) | - |
| Instituto de Salud Carlos III (ISCIII) | - |
| International Nut and Dried Fruit Council | - |
| ISCIII | CES09/030 |
| Karo Bio | - |
| Merck | - |
| Ministerio de Ciencia e Innovacion | AGL-2009-13906-C02; AGL2010-22319-C03 |
| Nestle | - |
| Novartis | - |
| Nutrexpa | - |
| Pace | - |
| Pfizer | - |
| Public Health Division of the Department of Health of the Autonomous Government of Catalonia and Generalitat Valenciana | ACOMP06109; GVACOMP2010-181; GVACOMP2011-151; CS2010-AP-111; CS2011-AP-042 |
| Recordati | - |
| Research Foundation on Wine and Nutrition (FIVIN) | - |
| Roche | - |
| Rottapharm | - |
| RTIC | RD 06/0045 |
| Synageva | - |
| Takeda | - |
| Unilever | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Instituto de Salud Carlos III; Clinica Universitaria de Navarra (Spain) | |
| 2 | Zazpe, I. | Instituto de Salud Carlos III; Universidad de Navarra (Spain) |
| 3 | Shivappa, N. | University of South Carolina (United States) |
| 4 | Hébert, J. R. | University of South Carolina (United States) |
| 5 | Sánchez-Tainta, A. | Instituto de Salud Carlos III (Spain) |
| 6 | Corella, D. | University of Valencia; Instituto de Salud Carlos III (Spain) |
| 7 | Salas-Salvadó, J. | Instituto de Salud Carlos III; University Hospital Sant Joan de Reus (Spain) |
| 8 | Fitó, M. | Instituto de Salud Carlos III; Hospital del Mar (Spain) |
| 9 | Lamuela-Raventós, R. M. | Universitat de Barcelona; Instituto de Salud Carlos III (Spain) |
| 10 | Rekondo, J. | Instituto de Salud Carlos III; University Hospital of Alava (Spain) |
| 11 | Fernández-Crehuet, J. | Universidad de Malaga; Instituto de Salud Carlos III (Spain) |
| 12 | Fiol, M. | Universitat de les Illes Balears; Instituto de Salud Carlos III (Spain) |
| 13 | Santos-Lozano, J. M. | Universidad de Sevilla; Instituto de Salud Carlos III (Spain) |
| 14 | Serra-Majem, L. | Instituto de Salud Carlos III; Universidad de Las Palmas de Gran Canaria (Spain) |
| 15 | Pinto, X. | Instituto de Salud Carlos III; Hospital Universitari de Bellvitge (Spain) |
| 16 | Martínez, J. A. | Instituto de Salud Carlos III; Universidad de Navarra (Spain) |
| 17 | Ros, E. | Instituto de Salud Carlos III; Institut d'Investigacions Biomèdiques August Pi i Sunyer - IDIBAPS (Spain) |
| 18 | Estruch, R. | Universitat de Barcelona; Instituto de Salud Carlos III (Spain) |
| 19 | Martínez-González, M. A. | Instituto de Salud Carlos III; Clinica Universitaria de Navarra (Spain) |
| # | Autoría grupal | Afiliación |
| 1 | Ortega-Calvo, M. (PREDIMED investigator) | Sin datos () |
